Skip to content

Clinical trials

Observational Metabolic Diseases trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolic Diseases Phase: Observational Country / region: Italy Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20121
20143
20161
20171
20191
20201
20211
20221
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting2
Unknown status2
Active, not recruiting1
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Messina4
Azienda Sanitaria-Universitaria Integrata di Udine1
Calcilytix Therapeutics, Inc., a BridgeBio company1
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta1
Fondazione Policlinico Universitario Agostino Gemelli IRCCS1
IRCCS Azienda Ospedaliero-Universitaria di Bologna1
IRCCS San Raffaele1
Ospedale San Donato1
Sumitomo Pharma Switzerland GmbH1
University of Bari1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolic Diseases14
Obesity4
Cardiovascular Diseases2
Genetic Diseases, Inborn2
Metabolic Syndrome2
Musculoskeletal Diseases2
Non-alcoholic Fatty Liver Disease2
Overweight2
Sphingolipidoses2
Adrenoleukodystrophy1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.